Screening for pancreatic cancer: What can cyst fluid analysis tell us?

F1000 Medicine Reports

Volumn 3, Issue 1, 2011, Pages

  Park, Walter G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; K RAS PROTEIN; MUCIN 1; MUCIN 5AC; MUTANT PROTEIN; PLECTIN; TUMOR MARKER;

CANCER SCREENING; CLINICAL PRACTICE; CYST FLUID; CYSTADENOMA; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PANCREAS CANCER; PRACTICE GUIDELINE; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW;

EID: 79551715836     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M3-3     Document Type: Review

References (18)

1. Fernández-del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL: Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003, 138:427-34. (Pubitemid 36417680)
2. Tanaka M, Chari S, Adsay V, Fernández-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
3. Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P: Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 2007, 56:1086-90.
4. Tang RS, Weinberg B, Dawson DW, Reber H, Hines OJ, Tomlinson JS, Chaudhari V, Raman S, Farrell JJ: Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2008, 6:815-9. (Pubitemid 351888940)
5. Pelaez-Luna M, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB: Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007, 102:1759-64.
6. Walsh RM, Vogt DP, Henderson JM, Hirose K, Mason T, Bencsath K, Hammel J, Brown N: Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery 2008, 144:677-85.
7. Allen PJ, D'Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, DeMatteo R, Fong Y, Blumgart LH, Brennan MF: Aselective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Ann Surg 2006, 244:572-82. (Pubitemid 44435766)
8. Correa-Gallego C, Ferrone CR, Thayer SP, Wargo JA, Warshaw AL, Fernández-Del Castillo C: Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 2010, 10:144-50.
9. Le Borgne J, de Calan L, Partensky C: Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999, 230:152-61. (Pubitemid 30191880)
10. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, del Castillo CF, Warshaw AL: Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004, 126:1330-6. (Pubitemid 38552797)
11. Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, Brugge WR, Edmundowicz SA, Hawes RH, McGrath KM: Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009, 69:1095-102.
12. van der Waaij LA, van Dullemen HM, Porte RJ: Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc 2005, 62:383-9.
13. Jacobson BC, Baron TH, Adler DG, Davila RE, Egan J, Hirota WK, Leighton JA, Qureshi W, Rajan E, Zuckerman MJ, Fanelli R, Wheeler- Harbaugh J, Faigel DO; American Society for Gastrointestinal Endoscopy: ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 2005, 61:363-70.
14. Das A, Wells CD, Nguyen CC: Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance? Am J Gastroenterol 2008, 103:1657-62.
15. Sawhney MS, Devarajan S, O'Farrel P, Cury MS, Kundu R, Vollmer CM, Brown A, Chuttani R, Pleskow DK: Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid. Gastrointest Endosc 2009, 69:1106-10.
16. Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A: Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. Ann Surg 2009, 250:754-60.
17. Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, Barnes D, Schmidt CM, Feng Z, Simeone DM: Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg 2010, 251:937-45.
18. Bausch D, Mino-Kenudson M, Fernandez-Del Castillo C, Warshaw AL, Kelly KA, Thayer SP: Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 2009, 13:1948-54.